HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.
Gender-specific cancers, such as gynecologic cancers and prostate cancer, are influenced by hormonal, genetic, and environmental factors. Gynecologic cancers include ovarian, cervical, and uterine cancers, requiring specialized screening and prevention programs. Prostate cancer, primarily affecting men, often progresses silently, highlighting the need for regular PSA testing. Treatment advancements, including minimally invasive surgeries, hormonal therapies, and immunotherapy, have improved survival rates. Research into hormone receptor pathways and genetic predispositions continues to inform targeted therapies. Awareness campaigns and gender-focused public health initiatives play a significant role in early detection and management, fostering better patient outcomes and reducing the global burden of these cancers.
